[18] FDA identified limitations in characterization data, potential immunogenicity concerns for injectable use, limited information for proposed routes, lack of established effectiveness for obesity, and insufficient long-term safety information
(1) F-actin formation is considered a key component in the cell's cytoskeleton, providing structure and aiding in cell movement
But a 2022 review concluded that there is not enough evidence to support this assumption
However, BPC-157 is not approved for human use by any regulatory agency, and its safety remains largely unproven
benefits are generally greatest when B12 or other nutrient status is genuinely low
"BPC 157 and the gut-brain axis: Implications for neuroprotection and mental health." Front Neurosci